1. Home
  2. NPKI vs AVXL Comparison

NPKI vs AVXL Comparison

Compare NPKI & AVXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NPKI
  • AVXL
  • Stock Information
  • Founded
  • NPKI 1932
  • AVXL 2004
  • Country
  • NPKI United States
  • AVXL United States
  • Employees
  • NPKI N/A
  • AVXL N/A
  • Industry
  • NPKI Metal Fabrications
  • AVXL Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • NPKI Industrials
  • AVXL Health Care
  • Exchange
  • NPKI Nasdaq
  • AVXL Nasdaq
  • Market Cap
  • NPKI 989.6M
  • AVXL 956.7M
  • IPO Year
  • NPKI N/A
  • AVXL N/A
  • Fundamental
  • Price
  • NPKI $10.93
  • AVXL $9.80
  • Analyst Decision
  • NPKI Strong Buy
  • AVXL Strong Buy
  • Analyst Count
  • NPKI 3
  • AVXL 2
  • Target Price
  • NPKI $12.17
  • AVXL $44.00
  • AVG Volume (30 Days)
  • NPKI 585.1K
  • AVXL 1.2M
  • Earning Date
  • NPKI 11-06-2025
  • AVXL 08-12-2025
  • Dividend Yield
  • NPKI N/A
  • AVXL N/A
  • EPS Growth
  • NPKI N/A
  • AVXL N/A
  • EPS
  • NPKI N/A
  • AVXL N/A
  • Revenue
  • NPKI $234,741,000.00
  • AVXL N/A
  • Revenue This Year
  • NPKI $19.94
  • AVXL N/A
  • Revenue Next Year
  • NPKI $9.36
  • AVXL N/A
  • P/E Ratio
  • NPKI N/A
  • AVXL N/A
  • Revenue Growth
  • NPKI 6.96
  • AVXL N/A
  • 52 Week Low
  • NPKI $4.76
  • AVXL $5.03
  • 52 Week High
  • NPKI $11.74
  • AVXL $14.44
  • Technical
  • Relative Strength Index (RSI)
  • NPKI 52.12
  • AVXL 58.71
  • Support Level
  • NPKI $11.15
  • AVXL $8.80
  • Resistance Level
  • NPKI $11.74
  • AVXL $10.04
  • Average True Range (ATR)
  • NPKI 0.31
  • AVXL 0.49
  • MACD
  • NPKI -0.06
  • AVXL 0.18
  • Stochastic Oscillator
  • NPKI 18.37
  • AVXL 73.79

About NPKI NPK International Inc. Common Stock

NPK International Inc is a temporary worksite access solutions company that manufactures, sells, and rents recyclable composite matting products, along with a full suite of services, including planning, logistics, and site restoration. The company generates majority of revenue from the rental of recyclable composite matting systems, along with related site construction and services to customers in various markets including power transmission, oil and natural gas exploration and production, pipeline, renewable energy, petrochemical, construction and other industries within the United States and United Kingdom.

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are further used in the analysis of clinical trials. The company's focus is on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its various therapeutic candidates in different stages of development include Anavex 2-73 (Blacamesine), Anavex 3-71 (AF710B), Anavex 1-41, and Anavex 1066.

Share on Social Networks: